Clinical trial Recruiting at 1 site Phase 4 Interventional Ages 18 to 89

Ketorolac for pain control after hip arthroscopy

Official title: Efficacy of Ketorolac for Postoperative Pain Management in Hip Arthroscopy: A Prospective, Randomized, Clinical Trial

Run by Henry Ford Health System · NCT07037888 · Data updated 2026-11-12

This will test whether ketorolac can control pain and reduce opioid use after hip arthroscopy in adults.

Quick facts

PhasePhase 4
Study typeInterventional
Ages18 Years to 89 Years
SexAll
Enrollment100 (estimated)
SponsorHenry Ford Health System
Academic / other
Locations1 site (Detroit, Michigan)
StatusRecruiting
StartedDecember 13, 2023
Main results expectedDecember 2026
Study endsDecember 2026
Registry record updatedNovember 6, 2026
Trial IDNCT07037888 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults over 18 with femoroacetabular impingement scheduled for hip arthroscopy with the enrolling surgeon at Henry Ford who can consent, speak English, are eligible for NSAID use, are not chronic opioid users, and are expected to be discharged the same day.

Probably not a fit

Patients with NSAID contraindications, a history of substance use disorder, chronic opioid use, inability to stop interacting medications, or those not discharged same day are unlikely to qualify or benefit from this protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a prospective, double-blinded, randomized trial at Henry Ford Health in Detroit comparing postoperative ketorolac to the standard opioid-based pain regimen in adults undergoing hip arthroscopy for femoroacetabular impingement. Participants are randomly assigned to receive ketorolac or the usual hydrocodone-acetaminophen protocol with blinding of patients and study staff. The trial measures postoperative pain scores and total opioid consumption, and excludes patients with NSAID contraindications, chronic opioid use, substance use disorder, or inability to be discharged the same day. Enrollment is limited to English-speaking adults able to consent and recover locally at the study center.

Why it matters

Potential benefit: If successful, the approach could provide effective pain relief while lowering postoperative opioid use and opioid-related side effects.

How similar studies have gone: Ketorolac and other NSAIDs have reduced opioid requirements after many types of surgery, but randomized data specifically for hip arthroscopy are limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients undergoing hip arthroscopy over the age of 18 with Dr. T. Sean Lynch
* Diagnosis of femoroacetabular impingement (FAI)

Exclusion Criteria:

* Patients with inability to consent and/or do not speak English
* Patients with conditions contraindicated with NSAIDs (medication allergy, peptic ulcer disease, bleeding diathesis, and renal disease)
* Patients with history of drug and alcohol use disorder
* Patients with chronic analgesia (filled two opioid prescriptions within 6 months of the surgery)
* Patients with psychotropic medication usage
* Patients who take pentoxifylline, probonecid, aspirin, and/or NSAIDs who cannot stop taking it for the study
* Patients who are not discharged same day after surgery

Where it's running

  • Henry Ford Health
    Detroit, Michigan, United States
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.